| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/16/2014 | US8914089 Noninvasive measurement of chemical substances |
| 12/16/2014 | US8912359 Bisbenzamidines for the treatment of pneumonia |
| 12/16/2014 | US8912355 Linoleic phospholipids and uses thereof for inhibiting inflammatory and neurodegenerative processes |
| 12/16/2014 | US8912354 Organopolysiloxane and cosmetic containing the same |
| 12/16/2014 | US8912337 Salts and polymorphs of dexrabeprazole |
| 12/16/2014 | US8912334 Biphenyl compounds useful as muscarinic receptor antagonists |
| 12/16/2014 | US8912331 3,5-disubstituted-3H-imidazo[4,5-B]pyridine and 3,5-disubstituted-3H-[1,2,3]triazolo[4,5-B] pyridine compounds as modulators of protein kinases |
| 12/16/2014 | US8912330 Azaindole derivatives as kinase inhibitors |
| 12/16/2014 | US8912329 Composition for treatment of tuberculosis |
| 12/16/2014 | US8912324 Optically active pyrazolylaminoquinazoline, and pharmaceutical compositions and methods of use thereof |
| 12/16/2014 | US8912323 Multifunctional small molecules |
| 12/16/2014 | US8912293 Resin composition, and prepeg and laminate prepared using the same |
| 12/16/2014 | US8912237 Stabilized carotenoid compositions |
| 12/16/2014 | US8912236 Pharmaceutical composition for delivery of receptor tyrosine kinase inhibiting (RTKi) compounds to the eye |
| 12/16/2014 | US8912234 Composition containing resveratrol and/or derivatives thereof and plant oil, process for producing said composition, nutraceutical and/or pharmaceutical product, and method for enhancing the potential of resveratrol |
| 12/16/2014 | US8912232 Use of oligomers of lactic acid in the treatment of gynaecological disorders |
| 12/16/2014 | US8912231 Method of treating airway remolding symptom |
| 12/16/2014 | US8912230 Method for treating cell degeneration using at least one molecule capable of inhibiting adhesion molecule expression and vascular endothelium actin fibre polymerization |
| 12/16/2014 | US8912229 Taxane and abeo-taxane analogs |
| 12/16/2014 | US8912228 Docetaxel formulations with lipoic acid |
| 12/16/2014 | US8912227 Bicyclic pyrrole derivatives useful as agonists of GPR120 |
| 12/16/2014 | US8912226 Pharmaceutical composition comprising (1r,4r) -6′-fluoro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine and a NSAR |
| 12/16/2014 | US8912225 VEGF inhibition |
| 12/16/2014 | US8912224 Substituted 2-(chroman-6-yloxy)-thiazoles and their use as pharmaceuticals |
| 12/16/2014 | US8912223 Compositions and processes for preparing 5-amino or substituted amino 1,2,3-triazoles and triazoles orotate formulations |
| 12/16/2014 | US8912221 Biaryl amide derivatives |
| 12/16/2014 | US8912220 Compounds and methods of use thereof |
| 12/16/2014 | US8912219 Aryl sulfamide and sulfamate derivatives as RORc modulators |
| 12/16/2014 | US8912217 Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder |
| 12/16/2014 | US8912216 Hetaryl-[1,8]naphthyridine derivatives |
| 12/16/2014 | US8912215 Rapamycin composition |
| 12/16/2014 | US8912214 Use of Chk2 kinase inhibitors for cancer treatment |
| 12/16/2014 | US8912213 Synthesis and use of dual tyrosyl-DNA phosphodiesterase I (TDP1)- topoisomerase I (TOP1) inhibitors |
| 12/16/2014 | US8912212 Therapeutic polymeric nanoparticle compositions with high glass transition temperature or high molecular weight copolymers |
| 12/16/2014 | US8912211 Medicinal compositions comprising buprenorphine and naltrexone |
| 12/16/2014 | US8912210 Piperidinone carboxamide azaindane CGRP receptor antagonists |
| 12/16/2014 | US8912209 Rock inhibitors |
| 12/16/2014 | US8912208 (4-{4-[5-(benzooxazol-2-ylamino)-pyridin-2-yl]-phenyl}-cyclohexyl)-acetic acid useful for treating or preventing conditions or disorders associated with DGAT1 activity |
| 12/16/2014 | US8912206 Pyrimidine ether derivatives and methods of use thereof |
| 12/16/2014 | US8912205 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 12/16/2014 | US8912204 Compounds and methods for kinase modulation, and indications therefor |
| 12/16/2014 | US8912203 6-(sulfonylaryl)pyrido[2,3-D]pyrimidin-7(8H)-ones for the treatment of CNS disorders |
| 12/16/2014 | US8912202 N-(benzimimdazol-2-yl)-cyclopropane carboxamides as lysophosphatidic acid antagonists |
| 12/16/2014 | US8912201 6-cycloalkyl-pyrazolopyrimidinones for the treatment of CNS disorders |
| 12/16/2014 | US8912200 Alkynyl substituted pyrimidinyl-pyrroles active as kinases inhibitors |
| 12/16/2014 | US8912199 Modulators of ATP-binding cassette transporters |
| 12/16/2014 | US8912198 Compounds useful as inhibitors of ATR kinase |
| 12/16/2014 | US8912197 Crystalline form of carbamoyl-cyclohexane derivatives |
| 12/16/2014 | US8912196 Piperazine, piperidine and tetrahydropyridine derivatives and their pharmaceutical use |
| 12/16/2014 | US8912195 Alkyl amides as HIV attachment inhibitors |
| 12/16/2014 | US8912194 CDK inhibitor for the treatment of mesothelioma |
| 12/16/2014 | US8912193 Dry powder inhaler and system for drug delivery |
| 12/16/2014 | US8912192 Extended release preparation |
| 12/16/2014 | US8912191 Pyrido[2,3-B]pyrazin-8-substituted compounds and their use |
| 12/16/2014 | US8912190 Substituted heterocyclic compounds |
| 12/16/2014 | US8912189 Pyridopyrazine derivatives and their use |
| 12/16/2014 | US8912188 Substituted quinoxaline carboxylic acids for the inhibition of PASK |
| 12/16/2014 | US8912187 Phthalazinone derivatives |
| 12/16/2014 | US8912186 Allosteric protein kinase modulators |
| 12/16/2014 | US8912185 Use of glutaric acid derivatives or the pharmaceutically acceptable salts thereof as anti-arrhythmic agents |
| 12/16/2014 | US8912184 Therapeutic and diagnostic methods |
| 12/16/2014 | US8912183 Substituted pyridazine derivatives |
| 12/16/2014 | US8912182 Viral polymerase inhibitors |
| 12/16/2014 | US8912181 Bicyclic compound or salt thereof |
| 12/16/2014 | US8912180 Heterocyclic compound |
| 12/16/2014 | US8912179 Heterocyclyl compounds as histamine H3 receptor ligands |
| 12/16/2014 | US8912178 mTOR selective kinase inhibitors |
| 12/16/2014 | US8912177 Method of treating polycystic kidney diseases with ceramide derivatives |
| 12/16/2014 | US8912176 Azetidines as histamine H3 receptor antagonists |
| 12/16/2014 | US8912175 Topical compositions for treatment of skin conditions |
| 12/16/2014 | US8912174 Formulations and methods for treating rhinosinusitis |
| 12/16/2014 | US8912173 Substituted quinolines and their use as medicaments |
| 12/16/2014 | US8912172 Skin external preparation containing triterpenic acid |
| 12/16/2014 | US8912171 Methods of use for 2,5-dihydroxybenzene sulfonic acid compounds for the treatment of cancer, rosacea and psoriasis |
| 12/16/2014 | US8912170 Prodrugs of 2,4-pyrimidinediamine compounds and their uses |
| 12/16/2014 | US8912169 Beta-lactamase inhibitors |
| 12/16/2014 | US8912168 Modified starch material of biocompatible hemostasis |
| 12/16/2014 | US8912167 Heparin-based compositions and methods for the inhibition of metastasis |
| 12/16/2014 | US8912166 Eye drops for treatment of conjunctivochalasis |
| 12/16/2014 | US8912165 Methods of skin treatment and use of water-soluble β-(1,3) glucans as active agents for producing therapeutic skin treatment agents |
| 12/16/2014 | US8912164 Re-epithelializing pharmaceutical compositions comprising xanthan gum |
| 12/16/2014 | US8912162 Parenteral formulations of elacytarabine derivatives |
| 12/16/2014 | US8912157 Treatment of pancreatic developmental gene related diseases by inhibition of natural antisense transcript to a pancreatic developmental gene |
| 12/16/2014 | US8912155 Method for analyzing secretome, biomarker for lung cancer metastasis, and siRNA compound for inhibiting lung cancer metastasis |
| 12/16/2014 | US8912151 Method of treating hemorrhoids using macrocyclic lactone compound |
| 12/16/2014 | US8912150 Ribosome structure and protein synthesis inhibitors |
| 12/16/2014 | US8912149 Glycosaminoglycan mimetics |
| 12/16/2014 | US8912144 Method for treating stroke via administration of NEP1-40 and inosine |
| 12/16/2014 | US8912141 Treatment of hepatitis C virus |
| 12/16/2014 | US8911982 Cells, nucleic acids, enzymes and use thereof, and methods for the production of sophorolipids |
| 12/16/2014 | US8911952 Method for integrin ligand discovery |
| 12/16/2014 | US8911950 Methods and compositions for inhibiting the growth of hematopoietic malignant cells |
| 12/16/2014 | US8911936 MicroRNA fingerprints during human megakaryocytopoiesis |
| 12/16/2014 | US8911935 Mitochondria and human immunodefiency virus type 1 |
| 12/16/2014 | US8911805 Calcium preparation and method of production thereof |
| 12/16/2014 | US8911804 Muscadine compositions with improved anti-oxidant activity |
| 12/16/2014 | US8911795 Compositions comprising dihydroavenanthramide D and climbazole as cosmetic and pharmaceutical compositions for alleviating itching |
| 12/16/2014 | US8911793 Algistatic water treatment solution and method of making |
| 12/16/2014 | US8911791 Method for acne treatment using an oxidative-photoactivated composition |
| 12/16/2014 | US8911787 Stable oral benzimidazole compositions and process of preparation thereof |